Warning: The NCBI web site requires JavaScript to function. more...
Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany. Stefan.Gebhardt@med.uni-marburg.de
We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on